Skip to main content
SPRC
NASDAQ Life Sciences

SciSparc Announces Deeply Discounted $0.77M Offering Amid Nasdaq Delisting Threat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.12
Mkt Cap
$4.029M
52W Low
$1
52W High
$19.089
52W Position info
12% above low
Off High info
94% below high
Rel. Volume info
20× avg
Market data snapshot near publication time

SPRC is trading near its 52-week low of $1 (12% above the low) on elevated volume (20× avg).

Summary

SciSparc Ltd. is conducting a registered direct offering of 766,170 ordinary shares at a significant discount, raising approximately $0.7 million, while simultaneously facing a Nasdaq delisting notice due to a stockholders' equity deficit.


Key Events · Financing and Capital Events · SPRC

  • Registered Direct Offering

    SciSparc is offering 766,170 ordinary shares to certain institutional and accredited investors.

  • Deep Discount Pricing

    Shares are priced at $1.00, a significant discount to the last reported sale price of $1.45 on January 12, 2026, and today's price of $1.12.

  • Substantial Dilution

    The offering will increase the number of outstanding shares by approximately 21.37%.

  • Nasdaq Non-Compliance

    The company received a notice on January 12, 2026, for failing to meet Nasdaq's minimum stockholders' equity requirement, reporting a deficit of approximately $81,000 as of June 30, 2025.


Analysis · SPRC · Life Sciences

This offering is a critical financing event for SciSparc, providing approximately $0.7 million in net proceeds for working capital and general corporate purposes. However, the offering is highly dilutive, increasing outstanding shares by over 21%, and is priced at a substantial discount to recent trading prices, indicating the company's urgent need for capital. The timing coincides with a Nasdaq notification of non-compliance with minimum stockholders' equity requirements, highlighting severe financial distress and a significant risk of delisting. While the capital raise provides a short-term lifeline, the terms and underlying financial issues present a strong negative signal for investors.

At the time of this filing, SPRC was trading at $1.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4M. The 52-week trading range was $1.00 to $19.09. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SPRC - Latest Insights

SPRC
Jul 15, 2026, 8:41 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.66
Real-time Price: $5.79 info
Change: +$1.13 (+24%) info
Market Cap: $3.318M info
SPRC
Jun 22, 2026, 1:46 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $6.93
Real-time Price: $5.79 info
Change: -$1.14 (-16%) info
Market Cap: $3.318M info
SPRC
Jun 03, 2026, 5:15 PM EDT
Source: TheNewswire
Importance Score:
7
Price at Filing: $9.45
Real-time Price: $5.79 info
Change: -$3.66 (-39%) info
Market Cap: $3.318M info
SPRC
May 29, 2026, 7:40 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $9.24
Real-time Price: $5.79 info
Change: -$3.45 (-37%) info
Market Cap: $3.318M info
SPRC
May 28, 2026, 8:40 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $4.54
Real-time Price: $5.79 info
Change: +$1.25 (+27%) info
Market Cap: $3.318M info